An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

Weight loss medications can reduce the efficacy of oral contraceptives. What to know before taking drugs like Ozempic, ...

Researchers say GLP-1 medicines might be able to help with migraines.

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

The plea alleged that licences for these drugs were given without appropriate scientific trials, data or noted potential ...

The Delhi High Court on Tuesday disposed of a public interest litigation (PIL) raising alarm over the off-label and ...

Senior Advocate Diya Kapur, representing the petitioner, informed the court that some gyms were promoting these drugs as a ...

The Delhi High Court has directed the Central Drugs Standard Control Organisation (CDSCO) and the Drug Controller General of ...

China represents an untapped market for GLP-1 class diabetes drugs, according to Novo Nordisk, which is predicting “good momentum” for its already-approved Victoza, and its successor semaglutide.

The latest attempt focuses on liraglutide, an older, once-daily injectable product in Novo Nordisk's GLP-1 agonist franchise sold as Victoza and Xultophy for diabetes and Saxenda for obesity.

Weight loss medications containing liraglutide could provide significant relief for millions of migraine sufferers, according ...

Lexaria Bioscience Corp., a global innovator in drug delivery platforms, announced that human study GLP-1-H25-5 which ...